Dunning KR, Cashman K, Russell DL, Thompson JG, Norman RJ, Robker RL
(IGFBP biology and cancer pathway context) Pollak M
While some peptides have relatively favorable safety profiles, proper oversight provides crucial benefits
Hohenfellner K, Rauch F, Ariceta G, Awan A, Bacchetta J, Bergmann C, Bechtold S, Cassidy N, Deschenes G, Elenberg E, Gahl WA, Greil O, Harms E, Herzig N, Hoppe B, Koeppl C, Lewis MA, Levtchenko E, Nesterova G, Santos F, Schlingmann KP, Servais A, Soliman NA, Steidle G, Sweeney C, Treikauskas U, Topaloglu R, Tsygin A, Veys K, R VV, Zustin J, Haffner D (2019) Management of bone disease in cystinosis: statement from an international conference
doi: 10.1093/pcp/pcy006 259 ZhengS